Contribution of adenosine receptors in the control of arteriolar tone and adenosine-angiotensin II interaction

Kidney International

Volumn 70, Issue 4, 2006, Pages 690-698

  Lai, E Y ^a   Patzak, A ^a,b   Steege, A ^b,c   Mrowka, R ^b   Brown, R ^a   Spielmann, N ^b   Persson, P B ^b   Fredholm, B B ^d   Persson, A E G ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adenosine; Adenosine type 1 receptor knockout mouse; Adenosine angiotensin II interaction; Afferent arteriole; Mouse

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR; ANGIOTENSIN RECEPTOR; MRS 1706; N (4 ACETYLPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY TONE; ARTICLE; CONTROLLED STUDY; KIDNEY BLOOD FLOW; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERFUSION; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION;

ADENOSINE; ANGIOTENSIN II; ANIMALS; ARTERIOLES; FEEDBACK; FEMALE; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENETHYLAMINES; PURINES; RECEPTOR, ADENOSINE A1; RECEPTORS, ADENOSINE A2; THEOPHYLLINE; TRIAZINES; TRIAZOLES; VASOCONSTRICTION; VASODILATION;

EID: 33747069362     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001650     Document Type: Article

References (26)

1. Hall JE, Granger JP, Hester RL. Interactions between adenosine and angiotensin II in controlling glomerular filtration. Am J Physiol 1985; 248(Part 2): F340-F346.
2. Osswald H. Renal effects of adenosine and their inhibition by theophylline in dogs. Naunyn Schmiedebergs Arch Pharmacol 1975; 288: 79-86.
3. Spielman WS, Thompson CI. A proposed role for adenosine in the regulation of renal hemodynamics and renin release. Am J Physiol 1982; 242: F423-F435.
4. Osswald H, Muhlbauer B, Schenk F. Adenosine mediates tubuloglomerular feedback response: an element of metabolic control of kidney function. Kidney Int Suppl 1991; 32: S128-S131.
5. Pflueger AC, Osswald H, Knox FG. Adenosine-induced renal vasoconstriction in diabetes mellitus rats: role of nitric oxide. Am J Physiol 1999; 276: F340-F346.
6. Franco M, Bell PD, Navar LG. Effect of adenosine A1 analogue on tubuloglomerular feedback mechanism. Am J Physiol 1989; 257(Part 2): F231-F236.
7. Schnermann J. Effect of adenosine analogues on tubuloglomerular feedback responses. Am J Physiol 1988; 255(Part 2): F33-F42.
8. Sun D, Samuelson LC, Yang T et al. Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci USA 2001; 98: 9983-9988.
9. Brown R, Ollerstam A, Johansson B et al. Abolished tubuloglomerular feedback and increased plasma renin in adenosine A(1) receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol 2001; 281: R1362-R1367.
10. Hansen PB, Schnermann J. Vasoconstrictor and vasodilator effects of adenosine in the kidney. Am J Physiol Renal Physiol 2003; 285: F590-F599.
11. Weihprecht H, Lorenz JN, Briggs JP, Schnermann J. Vasomotor effects of purinergic agonists in isolated rabbit afferent arterioles. Am J Physiol 1992; 263(Part 2): F1026-F1033.
12. Hansen PB, Castrop H, Briggs J, Schnermann J. Adenosine induces vasoconstriction through Gi-dependent activation of phospholipase C in isolated perfused afferent arterioles of mice. J Am Soc Nephrol 2003; 14: 2457-2465.
13. Nishiyama A, Inscho EW, Navar LG. Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity. Am J Physiol Renal Physiol 2001; 280: F406-F414.
14. Weihprecht H, Lorenz JN, Briggs JP, Schnermann J. Synergistic effects of angiotensin and adenosine in the renal microvasculature. Am J Physiol 1994; 266(Part 2): F227-F239.
15. Hansen PB, Hashimoto S, Briggs J, Schnermann J. Attenuated renovascular constrictor responses to angiotensin II in adenosine 1 receptor knockout mice. Am J Physiol Regul Integr Comp Physiol 2003; 285: R44-R49.
16. Schnermann J, Levine DZ. Paracrine factors in tubuloglomerular feedback: adenosine, ATP, and nitric oxide. Annu Rev Physiol 2003; 65: 501-529.
17. Traynor T, Yang T, Huang YG et al. Inhibition of adenosine-1 receptor-mediated preglomerular vasoconstriction in AT1A receptor-deficient mice. Am J Physiol 1998; 275(Part 2): F922-F927.
18. Traynor T, Yang T, Huang YG et al. Tubuloglomerular feedback in ACE-deficient mice. Am J Physiol 1999; 276(Part 2): F751-F757.
19. Fredholm BB, Abbracchio MP, Burnstock G et al. Nomenclature and classification of purinoceptors. Pharmacol Rev 1994; 46: 143-156.
20. Poucher SM, Keddie JR, Singh P et al. The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist. Br J Pharmacol 1995; 115: 1096-1102.
21. Tang L, Parker M, Fei Q, Loutzenhiser R. Afferent arteriolar adenosine A2a receptors are coupled to KATP in in vitro perfused hydronephrotic rat kidney. Am J Physiol 1999; 277(Part 2): F926-F933.
22. Johansson B, Halldner L, Dunwiddie TV et al. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci USA 2001; 98: 9407-9412.
23. Patzak A, Lai EY, Mrowka R et al. AT1 receptors mediate angiotensin II induced release of nitric oxide in afferent arterioles. Kidney Int 2004; 66: 1949-1958.
24. Chaudhari A, Kirschenbaum MA. A rapid method for isolating rabbit renal microvessels. Am J Physiol 1988; 254(Part 2): F291-F296.
25. Tichopad A, Dilger M, Schwarz G, Pfaffl MW. Standardized determination of real-time PCR efficiency from a single reaction set-up. Nucleic Acids Res 2003; 31: e122.
26. Jin X, Shepherd RK, Duling BR, Linden J. Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest 1997; 100: 2849-2857.